Nucleai adds Andy Harrison and Cris De Luca to Board along with raising $33m Series B financing led by Section 32 and Sanofi Ventures

– ISRAEL, Tel Aviv –  Nucleai, an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking the power of pathology data, today announced that it had closed a $33 million Series B financing round, jointly led by Section 32 and Sanofi Ventures along with existing investors Debiopharm, Fosun RZ Capital, Vertex Ventures, and Grove Ventures, also participating.…

Talent.com raises US$120m Series B funding round led by Inovia Capital

– SWITZERLAND, Lausanne / CANADA, Montreal –  Talent.com, the fast-growing global player in next-generation job search platforms, today announced a $120 million US Series B funding round led by Inovia Capital, alongside existing investor Caisse de dépôt et placement du Québec (CDPQ), and new investors Investissement Québec, Climb Ventures, BDC Capital, Fondaction, and HarbourVest Partners.…

Scenic Biotech adds Dr. Stephan Christgau, Dr. Michael Wacker and Stephane Verdood to Board along with raising €28 Series A financing

– NETHERLANDS, Amsterdam –  Scenic Biotech BV, a pioneer in the discovery of genetic modifiers today announced it has closed a €28 million Series A financing round co-led by Eir Ventures, BioMedPartners, and Vesalius Biocapital alongside existing investors Inkef Capital, BioGeneration Ventures, and Oxford Science Enterprises also participating.…